Success Metrics

Clinical Success Rate
86.2%

Based on 25 completed trials

Completion Rate
86%(25/29)
Active Trials
2(6%)
Results Posted
72%(18 trials)
Terminated
4(13%)

Phase Distribution

Ph phase_3
5
16%
Ph early_phase_1
1
3%
Ph phase_1
5
16%
Ph phase_2
11
34%
Ph not_applicable
4
13%
Ph phase_4
6
19%

Phase Distribution

6

Early Stage

11

Mid Stage

11

Late Stage

Phase Distribution32 total trials
Early Phase 1First-in-human
1(3.1%)
Phase 1Safety & dosage
5(15.6%)
Phase 2Efficacy & side effects
11(34.4%)
Phase 3Large-scale testing
5(15.6%)
Phase 4Post-market surveillance
6(18.8%)
N/ANon-phased studies
4(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.2%

25 of 29 finished

Non-Completion Rate

13.8%

4 ended early

Currently Active

2

trials recruiting

Total Trials

32

all time

Status Distribution
Active(2)
Completed(25)
Terminated(4)
Other(1)

Detailed Status

Completed25
Terminated4
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
2
Success Rate
86.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.1%)
Phase 15 (15.6%)
Phase 211 (34.4%)
Phase 35 (15.6%)
Phase 46 (18.8%)
N/A4 (12.5%)

Trials by Status

terminated413%
completed2578%
recruiting13%
unknown13%
active_not_recruiting13%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT05726292Phase 2

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Recruiting
NCT03124355Phase 1

Vagal Stimulation in POTS

Active Not Recruiting
NCT02554903Phase 2

Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation

Completed
NCT06217367Phase 4

Over-the-Counter Antihistamines & Heat Stress

Unknown
NCT05041946Phase 3

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

Completed
NCT01744093Not Applicable

Doxycycline for COPD in HIV-Infected Patients

Completed
NCT02045901Phase 4

A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Terminated
NCT00944658Phase 2

Spondylitis Trial of Apremilast for Better Rheumatic Therapy

Completed
NCT00781534Early Phase 1

A Clinical Trial of Ginseng in Diabetes

Completed
NCT01444170Phase 1

Nutritional Supplement, Eccentric Exercise and Recovery

Completed
NCT00715117Phase 2

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

Completed
NCT00957216Phase 1

Coenzyme Q10 in Adult-Onset Ataxia

Completed
NCT00310791Phase 2

Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

Completed
NCT01967628Phase 1

Human Lung Responses to Respiratory Pathogens

Completed
NCT01988402Phase 4

Does Allopurinol Prolong a Treated, Acute Gout Flare?

Completed
NCT00755716Phase 3

Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study

Completed
NCT00627705Phase 2

A Study of N-Acetyl Cysteine in Children With Autism

Completed
NCT01426347Not Applicable

Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis

Completed
NCT01347008Phase 3

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Completed
NCT01090180Not Applicable

Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD

Completed

Drug Details

Intervention Type
OTHER
Total Trials
32